BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1661787)

  • 1. [NADPH oxidase and cell membrane].
    Nunoi H; Matsuda I
    Rinsho Byori; 1991 Sep; Suppl 91():140-9. PubMed ID: 1661787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation mechanism of neutrophil NADPH oxidase complex--molecular pathology of chronic granulomatous disease].
    Umeki S
    Tanpakushitsu Kakusan Koso; 1994 Nov; 39(14):2284-96. PubMed ID: 7809374
    [No Abstract]   [Full Text] [Related]  

  • 3. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
    J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of chronic granulomatous disease.
    Curnutte JT
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):241-52. PubMed ID: 2839457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of p47phox and p67phox membrane translocation as the inhibitory mechanism of S-nitrosothiol on the respiratory burst oxidase in human neutrophils.
    Park JW
    Biochem Biophys Res Commun; 1996 Mar; 220(1):31-5. PubMed ID: 8602852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.
    Bolscher BG; van Zwieten R; Kramer IM; Weening RS; Verhoeven AJ; Roos D
    J Clin Invest; 1989 Mar; 83(3):757-63. PubMed ID: 2537848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock in human neutrophils: superoxide generation is inhibited by a mechanism distinct from heat-denaturation of NADPH oxidase and is protected by heat shock proteins in thermotolerant cells.
    Maridonneau-Parini I; Malawista SE; Stubbe H; Russo-Marie F; Polla BS
    J Cell Physiol; 1993 Jul; 156(1):204-11. PubMed ID: 8391007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane potential changes in polymorphonuclear leukocytes of patients with chronic granulomatous disease.
    Matsuura R; Kobayashi M; Usui T
    Hiroshima J Med Sci; 1984 Jun; 33(2):173-7. PubMed ID: 6480382
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic granulomatous disease: towards gene therapy.
    Thrasher A; Segal A; Casimir C
    Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the NADPH-oxidase: membrane components.
    Segal AW
    Immunodeficiency; 1993; 4(1-4):167-79. PubMed ID: 8167695
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation mechanism of NADPH oxidase by SDS in intact guinea pig neutrophils.
    Sasaki J; Hiura M; Yamaguchi M; Sakai M; Aoki K; Abe H; Okamura N; Ishibashi S
    Arch Biochem Biophys; 1994 Nov; 315(1):16-23. PubMed ID: 7979393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The respiratory burst oxidase.
    Babior BM
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):201-12. PubMed ID: 2839456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular bases of chronic granulomatous disease--analysis of the involvement of cytosol factors for NADPH oxidase].
    Nunoi H; Matsuda I
    Rinsho Byori; 1992 Apr; 40(4):380-4. PubMed ID: 1317471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the superoxide-producing enzyme of eosinophils and neutrophils--comparison of the NADPH oxidase components.
    Someya A; Nishijima K; Nunoi H; Irie S; Nagaoka I
    Arch Biochem Biophys; 1997 Sep; 345(2):207-13. PubMed ID: 9308891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient flavoprotein component of the NADPH-dependent O2-.-generating oxidase in the neutrophils from three male patients with chronic granulomatous disease.
    Gabig TG; Lefker BA
    J Clin Invest; 1984 Mar; 73(3):701-5. PubMed ID: 6707199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical subcellular fractionation of neutrophils from patients with chronic granulomatous disease. Demonstration of the enzyme defect in four cases.
    Segal AW; Peters TJ
    Q J Med; 1978 Apr; 47(186):213-20. PubMed ID: 684156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
    Schmid E; Figala V; Ullrich V
    Mol Pharmacol; 1994 May; 45(5):815-25. PubMed ID: 8190099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the human neutrophil superoxide-generating oxidase: studies in a reconstituted subcellular system.
    Clark RA; Volpp BD; Nauseef WM
    Trans Am Clin Climatol Assoc; 1989; 100():100-6. PubMed ID: 2855868
    [No Abstract]   [Full Text] [Related]  

  • 19. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI; Leto TL; Rotrosen D; Kwong CH; Malech HL
    Curr Opin Immunol; 1992 Feb; 4(1):53-6. PubMed ID: 1317712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p47phox mouse knock-out model of chronic granulomatous disease.
    Jackson SH; Gallin JI; Holland SM
    J Exp Med; 1995 Sep; 182(3):751-8. PubMed ID: 7650482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.